Risk factors for low bone mass in patients with ulcerative colitis following ileal pouch-anal anastomosis

American Journal of Gastroenterology

Volumn 104, Issue 3, 2009, Pages 639-646

  Shen, Bo ^a   Remzi, Feza H ^a   Oikonomou, Ioannis K ^a   Lu, Hong ^a   Lashner, Bret A ^a   Hammel, Jeffrey P ^a   Skugor, Mario ^a   Bennett, Ana E ^a   Brzezinski, Aaron ^a   Queener, Elaine ^a   Fazio, Victor W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CORTICOSTEROID; IMMUNOMODULATING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; VITAMIN D;

ADULT; ARTICLE; BONE DENSITY; BONE MASS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRAGILITY FRACTURE; HUMAN; HUMAN TISSUE; ILEOANAL ANASTOMOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OSTEOLYSIS; PREVALENCE; PRIORITY JOURNAL; PROCTOCOLECTOMY; RISK FACTOR; ULCERATIVE COLITIS;

ABSORPTIOMETRY, PHOTON; ADULT; BONE DENSITY; CALCIUM; COLITIS, ULCERATIVE; COLONIC POUCHES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; POUCHITIS; RISK FACTORS;

EID: 61949158692     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.78     Document Type: Article

References (52)

1. American Gastroenterological Association. American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 2003;124:791-4.
2. Bernstein CN, Seeger LL, Sayre JW et al. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995;10:250-6.
3. Pollak RD, Karmeli F, Eliakim R et al. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998;93:1483-90.
4. Pigot F, Roux C, Chaussade S et al. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 1992;37:1396-403.
5. Roux C, Abitbol V, Chaussade S et al. Bone loss in patients with inflammatory bowel disease: a prospective study. Osteoporos Int 1995;5:156-60.
6. Bjarnason I, Macpherson A, Mackintosh C et al. Reduced bone density in patients with inflammatory bowel disease. Gut 1997;40:228-33.
7. Silvennoinen JA, Karttunen TJ, Niemela SE et al. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995;37:71-6.
8. Jahnsen J, Falch JA, Aadland E et al. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997;40:313-9.
9. Schulte C, Dignass AU, Mann K et al. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflamm Bowel Dis 1998;4:268-75.
10. Robinson RJ, al-Azzawi F, Iqbal SJ et al. The relation of hand skin-fold thickness to bone mineral density in patients with Crohn's disease. Eur J Gastroenterol Hepatol 1997;9:945-9.
11. Ghosh S, Cowen S, Hannan WJ et al. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994;107:1031-9.
12. Jahnsen J, Falch JA, Mowinckel P et al. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol 2003;98:1556-62.
13. Bernstein CN, Leslie WD. Review article: Osteoporosis and inflammatory bowel disease. Aliment Pharmacol Ther 2004;19:941-52.
14. Habtezion A, Silverberg MS, Parkes R et al. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis 2002;8:87-92.
15. Reid IR. Relationships among body mass, its components, and bone. Bone 2002;31:547-55.
16. Siffledeen JS, Fedorak RN, Siminoski K et al. Bones and Crohn's-Risk factors associated with low bone mineral density in patients with Crohn's disease. Inflamm Bowel Dis 2004;10:220-8.
17. Bernstein CN, Leslie WD, Lebo: MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 2003;124:795-841.
18. Abreu MT, Geller JL, Vasiliauskas EA et al. Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease. J Clin Gastroenterol 2006;40:55-63.
19. Abitbol V, Roux C, Guillemant S et al. Bone assessment in patients with ileal pouch-anal anastomosis for inflammatory bowel disease. Br J Surg 1997;84:1551-4.
20. Jensen MB, Houborg KB, Vestergaard P et al. Improved physical performance and increased lean tissue and fat mass in patients with ulcerative colitis four to six years after ileoanal anastomosis with a J-pouch. Dis Colon Rectum 2002;45:1601-7.
21. Fazio VW, Ziv Y, Church JM et al. Ileal pouch-anal anastomosis. Complications and function in 1005 patients. Ann Surg 1995;222:120-7.
22. Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: Definition, pathogenesis, and treatment. Gastroenterology 1994;107:1856-60.
23. Shen B, Fazio VW, Remzi FH et al. Comprehensive evaluation of inflammatory and non-inflammatory sequelae of ileal pouch-anal anastomosis. Am J Gastroenterol 2005;100:93-101.
24. Kuisma J, Luukkonen P, Jarvinen H et al. Risk of osteopenia after proctocolectomy and ileal pouch-anal anastomosis for ulcerative colitis. Scand J Gastroenterol 2002;37:171-6.
25. Bernstein CN, Katz S. Guidelines for osteoporosis and inflammatory bowel disease. A guide to diagnosis and management for the gastroenterologist (monograph). Am Coll Gastroenterol 2003.
26. Sandborn WJ, Tremaine WJ, Batts KP et al. Pouchitis after ileal pouchanal anastomosis: A pouchitis disease activity index. Mayo Clin Proc 1994;69:409-15.
27. Shen B, Lashner BA, Achkar J-P et al. Modified pouchitis disease activity index: A simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 2003;46:748-53.
28. Wolf JM, Achkar JP, Lashner BA et al. Afferent limb ulcers predict Crohn's disease in patients with ileal pouch-anal anastomosis. Gastroenterology 2004;126:1686-91.
29. Shen B, Fazio VW, Remzi FH et al. Risk factors for clinical phenotypes of Crohn's disease of the pouch. Am J Gastroenterol 2006;101:2760-8.
30. Shen B, Achkar J-P, Lashner BA et al. Irritable pouch syndrome: A new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002;97:972-7.
31. Leib ES, Binkley N, Bilezikian JP et al. Position Development Conference of the International Society for Clinical Densitometry. Vancouver, BC, July 15-17, 2005. J Rheumatol 2006;33:2319-21.
32. A WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1-129.
33. Bernstein CN, Blanchard JF, Leslie W et al. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med 2000;133:795-9.
34. Loftus EV Jr, Crowson CS, Sandborn WJ et al. Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. Gastroenterology 2002;123:468-75.
35. Van Staa TP, Cooper C, Brusse LS et al. Inflammatory bowel disease and the risk of fracture. Gastroenterology 2003;125:1591-7.
36. Vestergaard P, Krogh K, Rejnmark L et al. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 2000;46:176-81.
37. Vestergaard P, Mosekilde L. Fracture risk in patients with celiac disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol 2002;156:1-10.
38. Staun M, Tjellesen L, Thale M et al. Bone mineral content in patients with Crohn's disease. A longitudinal study in patients with bowel resections. Scand J Gastroenterol 1997;32:226-32.
39. Chaussade S, Denizot Y, Valleur P et al. Presence of PAF-acether in stool of patients with pouch ileoanal anastomosis and pouchitis. Gastroenterology 1991;100:419-23.
40. Shepherd NA, Healey CJ, Warren BF et al. Distribution of mucosal morphology and an assessment of colonic phenotype change in the pelvic ileal reservoir. Gut 1993;34:101-5.
41. Biancone L, Palmieri G, Lombardi A et al. Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis. Am J Gastroenterol 2003;98:2719-26.
42. Natori H, Utsunomiya J, Yamamura T et al. Fecal and stomal bile acid composition after ileostomy or ileoanal anastomosis in patients with chronic ulcerative colitis and adenomatosis. Gastroenterology 1992;102:1278-87.
43. Salemans JMJ, Nagengast FM. Clinical and physiological aspects of ileal pouch-anal anastomosis. Scand J Gastroenterol 1996;30 (Suppl 212):3-12.
44. Nasmyth DG, Johnston D, Williams NS et al. Changes in the absorption of bile acids after total colectormy in patients with an ileostomy or pouch-anal anastomosis. Dis Colon Rectum 1989;32:230-4.
45. Lerch MM, Braun J, Harder M et al. Postoperative adaptation of the small intestine after total colectomy and J-pouch-anal anastomosis. Dis Colon Rectum 1989;32:600-8.
46. De Silva HJ, Kettlewell M, Mortensen MJ et al. Mucosal characteristics of pelvic ileal pouches. Gut 1991;32:61-5.
47. Clements MR, Chalmers TM, Fraser DR. Enterohepatic circulation of vitamin D. A reappraisal of the hypothesis. Lancet 1984;1:1376-9.
48. Iwamoto J, Takeda T, Ichimura S. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis. J Orthop Sci 2000;5:546-51.
49. Iwamoto J, Takeda T, Sato Y. Effects of vitamin K2 on osteoporosis. Curr Pharm Des 2004;10:2557-76.
50. Sasaki N, Kusano E, Takahashi H et al. Vitamin K2 inhibits glucocorticosteroid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG). J Bone Miner Metab 2005;23:41-7.
51. Ross PD, Davis JW, Epstein RS et al. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991;114:919-23.
52. Kornbluth A, Hayes M, Feldman S et al. Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria. Am J Gastroenterol 2006;101:1546-50.